Cellectar Biosciences
CLRB
CLRB
39 hedge funds and large institutions have $36.9M invested in Cellectar Biosciences in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.09% more ownership
Funds ownership: 0.04% → 0.13% (+0.09%)
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.47M | |
| 2 | +$3.71M | |
| 3 | +$3M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$2.01M |
| 5 |
6CM
683 Capital Management
New York
|
+$1.93M |
Top Sellers
| 1 | -$354K | |
| 2 | -$218K | |
| 3 | -$72K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$56K |
| 5 |
Squarepoint
New York
|
-$22K |